Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email